Reproducing SIVDnef vaccine correlates of protection: Trimeric gp41 antibody concentrated at mucosal front lines

AIDS

Volumn 30, Issue 16, 2016, Pages 2427-2438

  Voss, James E ^a   Macauley, Matthew S ^b   Rogers, Kenneth A ^c   Villinger, Francois ^c   Duan, Lijie ^d   Shang, Liang ^d   Fink, Elizabeth A ^e   Andrabi, Raiees ^a   Colantonio, Arnaud D ^f   Robinson, James E ^g   Paul Johnson, R ^h,i   Burton, Dennis R ^a,j   Haase, Ashley T ^d  

^a Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

Mucosal concentration; SIV VACCINE; Trimeric gp41 antibodies

Indexed keywords

ANTIGEN; GLYCOPROTEIN GP 41; PHOSPHORYL LIPID A; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; FC RECEPTOR; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; IMMUNOLOGICAL ADJUVANT; LIPID A; ONCOPROTEIN; TRANSMEMBRANE PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CHO CELL LINE; CONSENSUS SEQUENCE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIZE EXCLUSION CHROMATOGRAPHY; VACCINATION; VAGINA EPITHELIUM; ANIMAL; BAGG ALBINO MOUSE; EPITHELIUM; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LEPORIDAE; MUCOSAL IMMUNITY; SIMIAN IMMUNODEFICIENCY VIRUS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; EPITHELIUM; GENE PRODUCTS, ENV; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, MUCOSAL; INJECTIONS, INTRAMUSCULAR; LIPID A; MACACA MULATTA; MICE, INBRED BALB C; RABBITS; RECEPTORS, FC; RETROVIRIDAE PROTEINS, ONCOGENIC; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL FUSION PROTEINS;

EID: 84978676841     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001199     Document Type: Article

References (32)

1. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-223.
2. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005; 308:1582-1583.
3. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992; 258:1938-1941.
4. Johnson RP. Live attenuated AIDS vaccines: hazards and hopes. Nat Med 1999; 5:154-155.
5. Koff WC, Johnson RP, Watkins DW, Burton DR, Lifson JD, Hasenkrug KJ, et al. HIV vaccine design: insights from live attenuated SIV vaccines. Nat Immunol 2006; 7:19-23.
6. Reynolds MR, Weiler AM, Weisgrau KL, Piaskowski SM, Furlott JR, Weinfurter JT, et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 2008; 205:2537-2550.
7. Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, Weiker M, et al. Macaques vaccinated with simian immunodeficiency virus SIVmac239Dnef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J Virol 2010; 84:9190-9199.
8. Li Q, Zeng M, Duan L, Voss JE, Smith AJ, Pambuccian S, et al. Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry. J Immunol 2014; 193:3113-3125.
9. Baba T, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 1995; 267:1820-1825.
10. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 1999; 5:194-203.
11. Zolla-Pazner S. Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol 2004; 4:199-210.
12. Xu JY, Gorny MK, Palker T, Karwaska S, Zolla-Pazner S. Epitope mapping of two immunodominent domains of gp41, the transmembrane protein of HIV-1. Using ten human monoclonal antibodies. J Virol 1991; 65:4832-4838.
13. Moore PL, Crooks ET, Porter L, Zhu P, Cayanan CS, Grise H, et al. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J Virol 2006; 80:2515-2528.
14. Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines 2014; 2:159-182.
15. Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010; 10:787-796.
16. Caffrey M, Cai M, Kaufman J, Stahl SJ, Wingfield PT, Covell DG, et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 1998; 17:4572-4584.
17. Macauley MS, Pfrengle F, Rademacher C, Nycholat CM, Gale AJ, von Drygalski A, Paulson JC. Antigenic liposomes displaying Cd22 ligands induce antigen-specific B cell apoptosis. J Clin Invest 2013; 123:3074-3083.
18. Ye L, Zeng R, Bai Y, Roopenian DC, Zu X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol 2011; 29:158-163.
19. Murphey-Corb M, Wilson LA, Trichel AM, Roberts DE, Xu K, Ohkawa S, et al. Selective induction of protective MHC class Irestricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 1999; 162:540-549.
20. Robinson JE, Franco K, Elliott DH, Maher MJ, Reyna A, Montefiori D, et al. Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. J Virol 2010; 84:3443-3453.
21. Benoit RM, Wilhelm RN, Scherer-Becker D, Ostermeier C. An improved method for fast, robust, and seamless integration of DNA fragments into multiple plasmids. Protein Expr Purif 2006; 45:66-71.
22. Freissmuth D, Hiltgartner A, Stahl-Hennig C, Fuchs D, Tenner-Racz K, Racz P, et al. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Dnef and challenged with pathogenic SIVmac251. J Med Primatol 2010; 39:97-111.
23. Means RE, Greenough T, Desrosiers RC. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol 1997; 71:7895-7902.
24. Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, Neutra MR. Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr 2000; 24:297-309.
25. Pinter A, Honnen WJ, Tilley SA, Bona C, Zaghouani H, Gorny MK, Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol 1989; 63:2674-2679.
26. Parekh BS, Pau CP, Granade TC, Rayfield M, DeCock KM, Gayle H, et al. Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. AIDS 1991; 5:1009-1013.
27. Vogelstein B, Dintzis RZ, Dintzis HM. Specific cellular-stimulation in the primary immune-response-a quantized model. Proc Natl Acad Sci U S A 1982; 79:395-399.
28. Casella CR, Mitchell TC. Putting endotoxin to work for us: onophosphoryl lipid A is a safe and effective vaccine adjuvant. Cell Mol Life Sci 2008; 65:3231-3240.
29. Vollmer J, Krieg RM. Immunotherapeutic applications of CpG oligonucleotide TLR9 agonists. Adv Drug Deli Rev 2009; 61:195-204.
30. Stewart VA, McGrath S, Krieg AM, Larson NS, Angov E, Smith CL, et al. Activation of innate immunity in healthy Macaca mulatta by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques. Clin Vacc Immunol 2008; 15:221-226.
31. Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, Gettie A, et al. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol 1998; 72:7501-7509.
32. Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012; 491:463-467.